Skip to main content

Desvenlafaxine News

FDA Approves Khedezla for Major Depressive Disorder

July 10, 2013 – The United States Food and Drug Administration today approved Khedezla (desvenlafaxine) extended-release tablets for the treatment of major depressive disorder. Khedezla contains the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Major Depressive Disorder, Attention-Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Bipolar Disorder, Fibromyalgia, Hot Flashes, Narcolepsy, Neuralgia, Panic Disorder, Post Traumatic Stress Disorder, Postmenopausal Symptoms, Weight Loss (Obesity / Overweight)

Related drug support groups

Pristiq

Desvenlafaxine patient information at Drugs.com